Published in Cancer Weekly, December 4th, 2001
That pathway must include cellular expression of the mitogen vascular endothelial growth factor (VEGF) as well as the presence of a key receptor, flk-1(KDR), according to Alexandra Giatromanolaki and colleagues, Democritus University of Thrace, Alexandroupolis, Greece.
Giatromanolaki and a cohort of colleagues from around the world studied more than 120 endometrial carcinoma samples before coming to this conclusion. During their analyses, the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.